At a Glance
- Tasks: Lead the validation of TCR engagers for cancer immunotherapy development.
- Company: Join a pioneering biotech company revolutionising cancer treatment through innovative therapies.
- Benefits: Enjoy competitive pay, remote work flexibility, and a supportive team environment.
- Why this job: Be part of a mission-driven team making a real impact in cancer research.
- Qualifications: PhD in relevant fields with industry experience in bispecific or T-cell engager development required.
- Other info: Opportunity for career progression in a collaborative, hands-on culture.
The predicted salary is between 48000 - 84000 £ per year.
Are you an ambitious scientist with a PhD and/or industry experience in bispecific or T-cell engager development, eager to accelerate novel cancer immunotherapies?Join a pioneering biotechnology company at the forefront of engineering TCR engagers for immuno-oncology application. This role is critical to advancing novel therapeutic candidates rapidly towards clinical development, with an IND submission targeted within a year.The client are seeking a dynamic Senior or Principal Scientist to lead crucial in vivo and in vitro validation of TCR engagers.This role specifically requires bispecific or T-cell engager experience with IND-enabling processes.Your technical responsibilities will span:TCR design and characterization.Protein science operations, including expression, purification, and biophysical analysis (e.g., SPR – experience preferred but not essential).Molecular biology duties such as cloning, mutagenesis, DNA isolation, and preparing libraries for deep sequencing (emphasis on cloning and PCR preferred).Cellular and immunological assays (e.g., cell killing assays, flow cytometry, IncuCyte-based assays, ELISA).Tissue culture management.Experience with NGS analysis pipelines (specifically data analysis using R) is desired.Experience overseeing outsourced in vivo studies (without needing to have performed them yourself) is a plus.You\’ll thrive in a flat hierarchy where everyone contributes hands-on. This is a fantastic opportunity for career progression, offering a highly collaborative and supportive cross-disciplinary environment. The client offers very competitive compensation, with flexibility for remote work as project demands allow.If you hold a PhD in Immunology, Cell Biology, Biochemistry, or a related field with 1-2+ years (Senior) or 3+ years (Principal) of relevant industry experience, and possess critical experience with bispecific or TCR engager validation towards IND, apply now to learn more about this impactful role!
Senior / Principal Scientist employer: LinkedIn
Contact Detail:
LinkedIn Recruiting Team
StudySmarter Expert Advice 🤫
We think this is how you could land Senior / Principal Scientist
✨Tip Number 1
Network with professionals in the biotechnology and immuno-oncology fields. Attend relevant conferences, webinars, or local meetups to connect with others who may have insights into the hiring process or can refer you directly to our team.
✨Tip Number 2
Showcase your hands-on experience with TCR engagers and bispecific antibodies during informal discussions or interviews. Be prepared to discuss specific projects you've worked on and the impact they had on your previous organisations.
✨Tip Number 3
Familiarise yourself with the latest advancements in cancer immunotherapy and be ready to discuss how these developments could influence our work at StudySmarter. This will demonstrate your passion and commitment to the field.
✨Tip Number 4
Prepare thoughtful questions about our current projects and future directions in TCR engager development. This shows your genuine interest in the role and helps you stand out as a candidate who is proactive and engaged.
We think you need these skills to ace Senior / Principal Scientist
Some tips for your application 🫡
Tailor Your CV: Make sure your CV highlights your relevant experience in bispecific or T-cell engager development. Emphasise any specific projects or roles that align with the job description, particularly those involving IND-enabling processes.
Craft a Compelling Cover Letter: Write a cover letter that showcases your passion for cancer immunotherapy and your ambition as a scientist. Mention your PhD and any industry experience, and explain how your skills can contribute to the company's goals in advancing novel therapeutic candidates.
Highlight Technical Skills: In your application, clearly outline your technical skills related to TCR design, protein science operations, and molecular biology. If you have experience with NGS analysis pipelines or overseeing outsourced studies, make sure to include these details.
Showcase Collaborative Experience: Since the role involves working in a collaborative environment, provide examples of past experiences where you thrived in team settings. Highlight any cross-disciplinary projects that demonstrate your ability to work effectively with others.
How to prepare for a job interview at LinkedIn
✨Showcase Your Technical Expertise
Be prepared to discuss your experience with TCR design, bispecific or T-cell engager development, and any relevant molecular biology techniques. Highlight specific projects where you contributed to IND-enabling processes, as this will demonstrate your capability for the role.
✨Demonstrate Problem-Solving Skills
Expect questions that assess your ability to troubleshoot and innovate in a lab setting. Prepare examples of challenges you've faced in previous roles and how you overcame them, particularly in relation to in vivo and in vitro validation.
✨Emphasise Collaboration and Leadership
Since the company values a flat hierarchy, be ready to discuss your experience working in collaborative environments. Share instances where you led a project or mentored others, showcasing your ability to thrive in a team-oriented setting.
✨Prepare for Questions on Future Trends
Stay informed about the latest advancements in cancer immunotherapy and TCR engagers. Be ready to discuss how you see the field evolving and how your skills can contribute to the company's goals, especially regarding rapid clinical development.